Market revenue in 2023 | USD 86,750.6 million |
Market revenue in 2030 | USD 161,594.5 million |
Growth rate | 9.3% (CAGR from 2023 to 2030) |
Largest segment | Contract manufacturing |
Fastest growing segment | Contract Manufacturing |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Contract Development, Contract Manufacturing |
Key market players worldwide | Catalent Inc, Lonza Group Ltd, Recipharm, Siegfried Holding AG, Thermo Fisher Scientific Inc, Labcorp Drug Development, Jabil Inc, Syngene, IQVIA Holdings Inc, Almac Group, Ajinomoto Co Inc, Alcami, Vetter Pharma-Fertigung |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to healthcare contract development and manufacturing organization market will help companies and investors design strategic landscapes.
Contract manufacturing was the largest segment with a revenue share of 61.68% in 2023. Horizon Databook has segmented the U.S. healthcare contract development and manufacturing organization market based on contract development, contract manufacturing covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. holds the largest share in North America’s market and is projected to grow at a significant rate over the forecast period. Increase in outsourcing practices by pharmaceutical companies and support of CDMOs in reducing operational and capital expenses are among the key factors responsible for its lucrative growth.
Medical device companies in the U.S. are popular globally for their technologically advanced products. In addition, strong R&D practices in the country and promotion of new therapies have significantly contributed to the considerable market share held by the U.S. The cost and time involved in offshore production reduces overall cost-effectiveness and productivity of a manufacturing process.
Thus, improved productivity due to domestic manufacturing is anticipated to fuel the market. The need to maintain high client satisfaction amid intense competition is anticipated to further fuel the market in the country. According to a study by Consumer Reports, Inc., 8 out of 10 Americans prefer a product made in the U.S. over an imported one. According to Inc. magazine (Mansueto Ventures), nearly 85% of U.S. consumers believe that products made in the U.S. are of higher quality.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. healthcare contract development and manufacturing organization market , including forecasts for subscribers. This country databook contains high-level insights into U.S. healthcare contract development and manufacturing organization market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account